Hospital Universitario Torrecardenas — Clinical Trial Site

50 Registered trials

18 Currently recruiting

Organisation

Hospital Universitario Torrecardenas

Location

Almeria, Spain

Identifier

ORG-100043220

Address

Calle Paraje Torrecardenas S/n, 04009, Spain

Departments

#3467: Cardiología
3100: Cardiología
3186:Nefrología
Cardiology
Cardiology department
Cirugía
Coloproctología
Digestive
Digestivo
Endocrinology
Endocrinology and metabolism
Gastroenterology
Hematología
Hepatology Department
Hepatology Unit
infectious diseases
Internal Medicine
Internal medicine- Infectious Disease Department
Nefrologia
Nefrology
Nephrology
Neumologia
Neumology
Neurología
Neurology
Neuropediatrics
Oncology
Pediatrics
Peritoneal Oncological Surgery (carcinomatois)-Hepato-Bilio-Biliary-Pancreatic Surgery
Servicio de Angiología y Cirugía vascular
Servicio de Cardiologia
Servicio de Ginecología y Obstetricia
Servicio de Medicina Interna
Servicio de Nefrología
UCG Enfermedades Infecciosas, Microbiología y Medicina preventiva
Vascular Surgery

Clinical trials at this site (50)

Search interface

A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
A Phase 1/2a Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-DM1 in Subjects With … Pending

2024-513579-42-00 Type 1 Myotonic Dystrophy 7
Study to assess the safety and efficacy of multipotent mesenchymal stem cells administration as a treatment for patients with faecal inconti… Pending

2024-515766-13-00 Fecal incontinence 4
Efficacy of the use of neoadjuvant with/without hyperthermic intraperitoneal chemotherapy in the treatment of locally advanced colon cancer Pending

2025-520471-29-00 Locally advanced adenocarcinoma of the colon and upper 5
An Open Label Study to Assess the Effect of Patient Use and Robustness on Tiotropium Bromide Spray 2.5μg, Soft Mist Inhaler device Pending

2025-522412-16-00 Chronic obstructive pulmonary disease 3
Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Pending

2025-524103-69-00 Chronic Venous Insufficiency 10
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin ( ENLIGHTEN-6 ) Recruiting

2025-523659-73-00 Obesity 5 2026-05-11
A study to find out if BI 764198 helps adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS) Recruiting

2025-522191-86-00 Focal segmental glomerulosclerosis 5 2026-04-02
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Bacteriemia producida por P. aeruginosa. 6 2024-07-08
A phase 2b, randomized, double-blind study of redasemtide (S-005151) in adult participants with acute ischemic stroke Recruiting

2022-501890-38-00 acute ischemic stroke 4 2024-02-16
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
EFFICACY AND SAFETY OF MET097 ONCE WEEKLY IN PEOPLE WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (VESPER-5) Recruiting

2025-523975-48-00 Obesity 5 2026-05-08
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
Efficacy And Safety of MET097 Once Weekly In People With Overweight or Obesity (VESPER-4) Recruiting

2025-523974-18-00 Obesity 5 2026-04-30
A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta I… Recruiting

2024-517167-23-00 Chronic Hepatitis D Infection 5 2025-08-28
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin on clinical outcomes alone and how safe it is in adu… Recruiting

2023-506460-14-00 Chronic kidney disease (CKD) and hypertension. 5 2025-05-07
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept Recruiting

2024-516380-81-00 Treatment of IgAN 4 2025-02-28
Use of statins in patients with intracerebral hemorrhage Recruiting

2024-511465-11-00 Spontaneous lobar ICH 5 2024-11-20
Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH (ENLIGHTEN-Cirrhosis) Recruiting

2023-510395-31-00 Metabolic Dysfunction-Associated Steatohepatitis (MASH) 5 2024-10-30
A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab… Recruiting

2023-503224-66-00 Atrial Fibrillation 5 2023-10-31
A multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of iptacopan (LNP023) … Recruiting

2022-502160-20-00 Idiopathic Immune Complex Mediated Membranoproliferativ 5 2023-10-02
Multicentre Phase IV clinical trial to evaluate the efficacy of hyperthermic intraoperative chemotherapy (HIPEC) with Mitomycin-C after comp… Recruiting

2024-512726-28-00 peritoneal metastases of colorectal cancer 6 2022-02-14
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01